316 related articles for article (PubMed ID: 23019013)
1. G31P, an antagonist against CXC chemokine receptors 1 and 2, inhibits growth of human prostate cancer cells in nude mice.
Liu X; Peng J; Sun W; Yang S; Deng G; Li F; Cheng JW; Gordon JR
Tohoku J Exp Med; 2012 Oct; 228(2):147-56. PubMed ID: 23019013
[TBL] [Abstract][Full Text] [Related]
2. CXCR1/2 antagonism with CXCL8/Interleukin-8 analogue CXCL8(3-72)K11R/G31P restricts lung cancer growth by inhibiting tumor cell proliferation and suppressing angiogenesis.
Khan MN; Wang B; Wei J; Zhang Y; Li Q; Luan X; Cheng JW; Gordon JR; Li F; Liu H
Oncotarget; 2015 Aug; 6(25):21315-27. PubMed ID: 26087179
[TBL] [Abstract][Full Text] [Related]
3. CXCL8((3-73))K11R/G31P antagonizes ligand binding to the neutrophil CXCR1 and CXCR2 receptors and cellular responses to CXCL8/IL-8.
Li F; Zhang X; Gordon JR
Biochem Biophys Res Commun; 2002 May; 293(3):939-44. PubMed ID: 12051749
[TBL] [Abstract][Full Text] [Related]
4. Porcine CXCR1/2 antagonist CXCL8
Wang X; Li Y; Li L; Jiao Z; Liu X; Cheng G; Gu C; Hu X; Zhang W
Sci Rep; 2020 Jan; 10(1):1210. PubMed ID: 31988368
[TBL] [Abstract][Full Text] [Related]
5. Humanized forms of the CXCR1/CXCR2 antagonist, bovine CXCL8((3-74))K11R/G31P, effectively block ELR-CXC chemokine activity and airway endotoxemia pathology.
Zhao X; Li F; Town JR; Zhang X; Wang W; Gordon JR
Int Immunopharmacol; 2007 Dec; 7(13):1723-31. PubMed ID: 17996682
[TBL] [Abstract][Full Text] [Related]
6. The combined CXCR1/CXCR2 antagonist CXCL8(3-74)K11R/G31P blocks neutrophil infiltration, pyrexia, and pulmonary vascular pathology in endotoxemic animals.
Gordon JR; Li F; Zhang X; Wang W; Zhao X; Nayyar A
J Leukoc Biol; 2005 Dec; 78(6):1265-72. PubMed ID: 16204619
[TBL] [Abstract][Full Text] [Related]
7. CXCR1/CXCR2 antagonist G31P inhibits nephritis in a mouse model of uric acid nephropathy.
Ye Y; Zhang Y; Wang B; Walana W; Wei J; Gordon JR; Li F
Biomed Pharmacother; 2018 Nov; 107():1142-1150. PubMed ID: 30257327
[TBL] [Abstract][Full Text] [Related]
8. The antagonist of CXCR1 and CXCR2 protects
Cui S; Qiao L; Yu S; Men L; Li Y; Li F; Du J
Am J Physiol Endocrinol Metab; 2019 Dec; 317(6):E1205-E1217. PubMed ID: 31573846
[TBL] [Abstract][Full Text] [Related]
9. Ladarixin, a dual CXCR1/2 inhibitor, attenuates experimental melanomas harboring different molecular defects by affecting malignant cells and tumor microenvironment.
Kemp DM; Pidich A; Larijani M; Jonas R; Lash E; Sato T; Terai M; De Pizzol M; Allegretti M; Igoucheva O; Alexeev V
Oncotarget; 2017 Feb; 8(9):14428-14442. PubMed ID: 28129639
[TBL] [Abstract][Full Text] [Related]
10. Combined CXCR1/CXCR2 antagonism decreases radiation-induced alveolitis in the mouse.
Fox J; Gordon JR; Haston CK
Radiat Res; 2011 May; 175(5):657-64. PubMed ID: 21342009
[TBL] [Abstract][Full Text] [Related]
11. GDC-0941 and CXCL8 (3-72) K11R/G31P combination therapy confers enhanced efficacy against breast cancer.
Li X; Zhang Y; Walana W; Zhao F; Li F; Luo F
Future Oncol; 2020 May; 16(14):911-921. PubMed ID: 32285685
[No Abstract] [Full Text] [Related]
12. ELR-CXC chemokine receptor antagonism targets inflammatory responses at multiple levels.
Zhao X; Town JR; Li F; Zhang X; Cockcroft DW; Gordon JR
J Immunol; 2009 Mar; 182(5):3213-22. PubMed ID: 19234219
[TBL] [Abstract][Full Text] [Related]
13. G31P, CXCR1/2 inhibitor, with cisplatin inhibits the growth of mice hepatocellular carcinoma and mitigates high‑dose cisplatin-induced nephrotoxicity.
Li L; Khan MN; Li Q; Chen X; Wei J; Wang B; Cheng JW; Gordon JR; Li F
Oncol Rep; 2015 Feb; 33(2):751-7. PubMed ID: 25504010
[TBL] [Abstract][Full Text] [Related]
14. Characterization of gastrin-induced proangiogenic effects in vivo in orthotopic U373 experimental human glioblastomas and in vitro in human umbilical vein endothelial cells.
Lefranc F; Mijatovic T; Mathieu V; Rorive S; Decaestecker C; Debeir O; Brotchi J; Van Ham P; Salmon I; Kiss R
Clin Cancer Res; 2004 Dec; 10(24):8250-65. PubMed ID: 15623601
[TBL] [Abstract][Full Text] [Related]
15. CXCR1/CXCR2 antagonist CXCL8(3-74)K11R/G31P blocks lung inflammation in swine barn dust-instilled mice.
Schneberger D; Gordon JR; DeVasure JM; Boten JA; Heires AJ; Romberger DJ; Wyatt TA
Pulm Pharmacol Ther; 2015 Apr; 31():55-62. PubMed ID: 25681618
[TBL] [Abstract][Full Text] [Related]
16. IL-8 analogue CXCL8 (3-72) K11R/G31P, modulates LPS-induced inflammation via AKT1-NF-kβ and ERK1/2-AP-1 pathways in THP-1 monocytes.
Walana W; Wang JJ; Yabasin IB; Ntim M; Kampo S; Al-Azab M; Elkhider A; Dogkotenge Kuugbee E; Cheng JW; Gordon JR; Li F
Hum Immunol; 2018 Nov; 79(11):809-816. PubMed ID: 30125599
[TBL] [Abstract][Full Text] [Related]
17. Effects of K11R and G31P Mutations on the Structure and Biological Activities of CXCL8: Solution Structure of Human CXCL8
Cheng HT; Yu HY; Gordon JR; Li F; Cheng JW
Molecules; 2017 Jul; 22(7):. PubMed ID: 28754019
[TBL] [Abstract][Full Text] [Related]
18. Repertaxin, an inhibitor of the chemokine receptors CXCR1 and CXCR2, inhibits malignant behavior of human gastric cancer MKN45 cells in vitro and in vivo and enhances efficacy of 5-fluorouracil.
Wang J; Hu W; Wang K; Yu J; Luo B; Luo G; Wang W; Wang H; Li J; Wen J
Int J Oncol; 2016 Apr; 48(4):1341-52. PubMed ID: 26847910
[TBL] [Abstract][Full Text] [Related]
19. Actin filaments are involved in the regulation of trafficking of two closely related chemokine receptors, CXCR1 and CXCR2.
Zaslaver A; Feniger-Barish R; Ben-Baruch A
J Immunol; 2001 Jan; 166(2):1272-84. PubMed ID: 11145710
[TBL] [Abstract][Full Text] [Related]
20. CXCL8 Antagonist Improves Diabetic Nephropathy in Male Mice With Diabetes and Attenuates High Glucose-Induced Mesangial Injury.
Cui S; Zhu Y; Du J; Khan MN; Wang B; Wei J; Cheng JW; Gordon JR; Mu Y; Li F
Endocrinology; 2017 Jun; 158(6):1671-1684. PubMed ID: 28387853
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
